Today’s Short Interest: ARNO THERAPEUTICS (OTCMKTS:ARNI) Could Improve Your Long Portfolio After Less Shorts Reported

November 24, 2016 - By Vivian Park   ·   0 Comments

Today's Short Interest: ARNO THERAPEUTICS (OTCMKTS:ARNI) Could Improve Your Long Portfolio After Less Shorts Reported

The stock of ARNO THERAPEUTICS (OTCMKTS:ARNI) registered a decrease of 53.9% in short interest. ARNI’s total short interest was 6,500 shares in November as published by FINRA. Its down 53.9% from 14,100 shares, reported previously. With 5,100 shares average volume, it will take short sellers 1 days to cover their ARNI’s short positions. The stock closed at $0.3 during the last session. It is down 23.08% since April 22, 2016 and is downtrending. It has underperformed by 28.49% the S&P500.

Arno Therapeutics, Inc. is an early-stage firm focused on developing products for the treatment of cancer and other life threatening diseases. The company has a market cap of $13.46 million. The Company’s product development pipeline includes Onapristone, AR-42, and AR-12 and analogs. It currently has negative earnings. Onapristone is indicated for endometrial, prostate and breast cancer indications.

ARNI Company Profile

Arno Therapeutics, Inc., incorporated on March 8, 2000, is an early-stage firm focused on developing products for the treatment of cancer and other life threatening diseases. The Company’s product development pipeline includes Onapristone, AR-42, and AR-12 and analogs. Onapristone is indicated for endometrial, prostate and breast cancer indications. AR-42 is provided for hematological malignancies and solid tumors indications. AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.

More notable recent Arno Therapeutics Inc (OTCMKTS:ARNI) news were published by: Businesswire.com which released: “Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update” on November 14, 2016, also Businesswire.com with their article: “Arno Therapeutics Reports Second Quarter 2016 Financial and Business Update” published on August 22, 2016, Seekingalpha.com published: “Past Failures Set Arno Therapeutics Up For Success.” on January 28, 2016. More interesting news about Arno Therapeutics Inc (OTCMKTS:ARNI) were released by: Globenewswire.com and their article: “Arno Therapeutics Completes $7.4 Million Common Stock Financing” published on January 13, 2016 as well as Globenewswire.com‘s news article titled: “Arno Therapeutics to Focus Clinical Developmental Activities on Advanced …” with publication date: April 19, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Vivian Park


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>